GRCE vs NPWR-WS
Comparison between Acasti Pharma Inc (GRCE, Company) and NET Power Inc - Warrants (01/01/9999) (NPWR-WS, Company).
GRCE vs NPWR-WS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
GRCE
$33M
NPWR-WS
$33M
Max Drawdown
Winner
GRCE
60.00%
NPWR-WS
95.68%
Sharpe Ratio
Winner
GRCE
-0.12
NPWR-WS
-3.16
5Y Beta
Winner
GRCE
0.87
NPWR-WS
2.45
Industry
GRCE
Biotechnology
NPWR-WS
N/A
P/E Ratio
Winner
GRCE
-3.91
NPWR-WS
-0.05
Forward P/E
GRCE
2.17
NPWR-WS
N/A
PEG Ratio
GRCE
N/A
NPWR-WS
-0.00
Debt to Equity
GRCE
0.00%
NPWR-WS
0.00%
Free Cash Flow Yield
GRCE
-26.61%
NPWR-WS
N/A
P/S Ratio
GRCE
197.75
NPWR-WS
N/A
P/B Ratio
GRCE
0.57
NPWR-WS
N/A
GRCE vs NPWR-WS - Historical Returns
Returns include dividend reinvestment.
1M
Winner
GRCE
-7.14%
NPWR-WS
-35.59%
3M
GRCE
-11.11%
NPWR-WS
N/A
6M
GRCE
-42.70%
NPWR-WS
N/A
1Y
GRCE
-28.03%
NPWR-WS
N/A
Max(CAGR)
Winner
GRCE
-18.62%
NPWR-WS
-60.53%
GRCE vs NPWR-WS - Annual Returns (2023 - 2026)
Returns include dividend reinvestment.
| Year | GRCE | NPWR-WS |
|---|---|---|
| 2026 | -43.17% | -50.39% |
| 2025 | -13.50% | N/A |
| 2024 | +23.84% | N/A |
| 2023 | N/A | +0.00% |
GRCE vs NPWR-WS Drawdown Comparison
The maximum drawdown for GRCE was -60.00%, occurring on Apr 7, 2025. Recovery took 323 trading sessions.
The maximum drawdown for NPWR-WS was -95.68%, occurring on Jul 28, 2026. This drawdown has not yet recovered.
The current GRCE drawdown is -59.45%. The current NPWR-WS drawdown is -94.62%.
| Rank | GRCE | NPWR-WS |
|---|---|---|
| #1 | -60.00% Dec 6, 2024 - Mar 25, 2026 | -95.68% Jun 9, 2023 - Jul 28, 2026 |
| #2 | -59.65% Apr 2, 2026 - Jul 30, 2026 | N/A |
| #3 | -18.06% Oct 23, 2024 - Dec 4, 2024 | N/A |
| #4 | -8.60% Mar 26, 2026 - Apr 1, 2026 | N/A |
| #5 | -5.57% Oct 10, 2024 - Oct 23, 2024 | N/A |
Correlation
Correlation between GRCE and NPWR-WS is 0.98 which considered as a very strong positive correlation - the stocks move almost identically together.
0.98
-101
Select Stocks to Compare
Popular: GRCE vs SPYNPWR-WS vs SPY
More Comparisons
Compare with similar stocks